DCD approval processes hold a crucial role in driving innovation within the healthcare industry. By implementing streamlined strategies, regulatory bodies can expedite the creation of new medications that have the capacity to enhance patient care. Furthermore, a more streamlined approval process can incentivize investment in innovation, leading to